The country’s wavering stance on data exclusivity, which will allow corporations to hold a monopoly on drugs, risks global ...

The Supreme Court agreed to review a controversy over so-called skinny labels for medicines, a decision that will be closely ...

For the first time, patients whose prostate cancer has not spread will be eligible for the drug abiraterone in England, after ...

Scientists are searching for therapeutics that mimic the life-extending benefits of caloric restriction, exercise, and a good ...

Medicare drug coverage can help you handle the rising cost of prescriptions. If you're covered by Original Medicare, some Medicare Cost Plans, Medicare Private Fee-For-Service Plans, or Medicare ...

This flu season has been rough. Antivirals can help.

Can you — should you — keep expanding at this pace?” “Yes, we can… and yes, we should…. We would be crazy not to.” ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. Join us Jan. 14 for a virtual discussion about our Rx ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

President Donald Trump has been successful in convincing many of the world’s top drugmakers to commit to manufacturing more of their prescription treatments in the U.S. But what about the onshoring of ...

WASHINGTON, Dec 3 (Reuters) - AT&T (T.N), opens new tab and its employee benefit trust have sued dozens of generic drug manufacturers in U.S. federal court, accusing them of orchestrating an ...